Insider Transactions in Q3 2024 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,230
$923.54 P/Share
|
|
Sep 16
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,768
$923.54 P/Share
|
|
Sep 16
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$10,153
$923.54 P/Share
|
|
Sep 16
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.71%
|
$10,153
$923.54 P/Share
|
|
Sep 16
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,999
$923.54 P/Share
|
|
Sep 11
2024
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
5,724
-4.63%
|
-
|
|
Sep 10
2024
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
SELL
Bona fide gift
|
Direct |
111
-0.09%
|
-
|
|
Sep 03
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
24,084
-0.01%
|
$23,289,228
$967.74 P/Share
|
|
Aug 27
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
24,552
-0.0%
|
$23,790,888
$969.44 P/Share
|
|
Aug 26
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-10.52%
|
$712,500
$950.0 P/Share
|
|
Aug 22
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,196
-0.0%
|
$3,087,336
$966.64 P/Share
|
|
Aug 20
2024
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
13,727
-2.84%
|
-
|
|
Aug 19
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,210
$921.81 P/Share
|
|
Aug 19
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$14,736
$921.81 P/Share
|
|
Aug 19
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.5%
|
$10,131
$921.81 P/Share
|
|
Aug 19
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,973
$921.81 P/Share
|
|
Aug 19
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.72%
|
$10,131
$921.81 P/Share
|
|
Aug 12
2024
|
Anat Hakim EVP, GC & Secretary |
SELL
Bona fide gift
|
Direct |
14,700
-48.23%
|
-
|
|
Jul 15
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.37%
|
$9,500
$950.46 P/Share
|
|
Jul 15
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.1%
|
$15,200
$950.46 P/Share
|
|
Jul 15
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.46%
|
$9,500
$950.46 P/Share
|
|
Jul 15
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$11,400
$950.46 P/Share
|
|
Jul 15
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.66%
|
$9,500
$950.46 P/Share
|
|
Jul 10
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.02%
|
$197,400,000
$940.98 P/Share
|
|
Jul 08
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
93,593
-0.01%
|
$86,199,153
$921.69 P/Share
|
|
Jul 05
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
52,369
-0.03%
|
$47,917,635
$915.7 P/Share
|
|
Jul 03
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
8,848
-0.0%
|
$8,104,768
$916.36 P/Share
|
|
Jul 01
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
58,749
-0.03%
|
$53,755,335
$915.73 P/Share
|